Toward Drug Repurposing in Epigenetics: Olsalazine as a Hypomethylating Compound Active in a Cellular Context

By  

CHEMMEDCHEM, Vol. 9, Iss. 3, 2014-03 ,pp. : 560-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Studies toward New Anti-Cancer Strategies Based on α-Mannosidase Inhibition

By Gerber-Lemaire Sandrine  

CHIMIA International Journal for Chemistry, Vol. 64, Iss. 9, 2010-09 ,pp. : 634-639

Swiss Chemical Society

Access to resources Recommend Favorite

Paraptosis‐Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer Therapy

By  

SMALL, Vol. 14, Iss. 7, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Toward a Novel Drug To Target the EGF–EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides

By  

CHEMBIOCHEM, Vol. 19, Iss. 1, 2018-01 ,pp. : 76-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heparin‐Engineered Mesoporous Iron Metal‐Organic Framework Nanoparticles: Toward Stealth Drug Nanocarriers

By  

ADVANCED HEALTHCARE MATERIALS (ELECTRONIC), Vol. 4, Iss. 8, 2015-06 ,pp. : 1246-1257

John Wiley & Sons Inc

Access to resources Recommend Favorite